ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

NCI Advisory Group, Other Cancer Meetings

August 19, 1983

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994